NASDAQ:CERN - Cerner Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $70.14 -0.01 (-0.01 %) (As of 05/22/2019 04:00 PM ET)Previous Close$70.15Today's Range$69.80 - $70.4152-Week Range$48.78 - $70.76Volume146,316 shsAverage Volume2.52 million shsMarket Capitalization$22.83 billionP/E Ratio31.78Dividend YieldN/ABeta1.03 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and EHR agnostic platform, CareAware that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions. Further, it provides tech-enabled services, such as implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third-party administrator services; and complementary hardware and devices for third parties. The company serves integrated integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments and public health organizations. It has a strategic collaboration with Christiana Care Health System to provide a weight loss surgery program. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri. Receive CERN News and Ratings via Email Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer integrated systems design Sub-IndustryHealth Care Technology SectorMedical Current SymbolNASDAQ:CERN Previous Symbol CUSIP15678210 CIK804753 Webhttp://www.cerner.com/ Phone816-221-1024Debt Debt-to-Equity Ratio0.09 Current Ratio2.58 Quick Ratio2.55Price-To-Earnings Trailing P/E Ratio31.78 Forward P/E Ratio28.75 P/E Growth2.1 Sales & Book Value Annual Sales$5.37 billion Price / Sales4.25 Cash Flow$4.3592 per share Price / Cash Flow16.09 Book Value$15.76 per share Price / Book4.45Profitability EPS (Most Recent Fiscal Year)$2.21 Net Income$630.05 million Net Margins11.65% Return on Equity14.86% Return on Assets11.00%Miscellaneous Employees29,200 Outstanding Shares325,421,000Market Cap$22.83 billion Next Earnings Date8/1/2019 (Estimated) OptionableOptionable Cerner (NASDAQ:CERN) Frequently Asked Questions What is Cerner's stock symbol? Cerner trades on the NASDAQ under the ticker symbol "CERN." How will Cerner's stock buyback program work? Cerner declared that its Board of Directors has approved a share buyback program on Sunday, June 4th 2017, which authorizes the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 2.3% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued. How were Cerner's earnings last quarter? Cerner Co. (NASDAQ:CERN) released its earnings results on Thursday, April, 25th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.55 by $0.06. The company had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.39 billion. Cerner had a net margin of 11.65% and a return on equity of 14.86%. Cerner's revenue for the quarter was up 7.5% compared to the same quarter last year. During the same period last year, the company earned $0.58 EPS. View Cerner's Earnings History. When is Cerner's next earnings date? Cerner is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for Cerner. What guidance has Cerner issued on next quarter's earnings? Cerner issued an update on its FY19 earnings guidance on Thursday, April, 25th. The company provided earnings per share (EPS) guidance of $2.64-2.72 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.65. The company issued revenue guidance of $5.650-5.850 billion, compared to the consensus revenue estimate of $5.74 billion.Cerner also updated its FY 2019 guidance to $2.64-2.72 EPS. What price target have analysts set for CERN? 15 brokers have issued 12-month target prices for Cerner's shares. Their forecasts range from $49.00 to $77.00. On average, they anticipate Cerner's share price to reach $69.5333 in the next twelve months. This suggests that the stock has a possible downside of 0.9%. View Analyst Price Targets for Cerner. What is the consensus analysts' recommendation for Cerner? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerner in the last year. There are currently 1 sell rating, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerner. What are Wall Street analysts saying about Cerner stock? Here are some recent quotes from research analysts about Cerner stock: 1. Cantor Fitzgerald analysts commented, "Our rating remains Overweight and our PT remains $75. Although some amount of investor skepticism regarding the company’s growth outlook continues to temper valuation levels, we do not share those concerns. Our long-term DCF model assumptions are mostly conservative, with high single-digit revenue growth and modest margin expansion. Capital spending should moderate in 2019. We think the shares offer a compelling risk/reward trade off. Valuation Summary Cerner shares trade at a 32% discount to our DCF-based price target of $75." (4/9/2019) 2. According to Zacks Investment Research, "Cerner continues to witness strong contributions from its key areas, including Population Health, Revenue Cycle and IT Works. Strong international performance in recent times is an added positive. Further, gains in Professional and Managed Services units buoy optimism. The company is likely to benefit from EHR, EPR or EMR platforms that provide patient care in both acute inpatient and outpatient settings. On the flip side, the company’s Licensed Software and Subscriptions revenues witnessed a year-over-year decline in the last reported quarter. In fact, management expects low software bookings to negatively impact total bookings in the upcoming quarter. The contraction in operating margin adds to the woes. Furthermore, high long-term debt and competition in the global HCIT space are worrisome. Cerner has underperformed its industry in a year's time." (4/8/2019) Has Cerner been receiving favorable news coverage? Media coverage about CERN stock has been trending negative on Wednesday, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cerner earned a news sentiment score of -2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. Who are some of Cerner's key competitors? Some companies that are related to Cerner include Altaba (AABA), Godaddy (GDDY), Open Text (OTEX), Leidos (LDOS), Jack Henry & Associates (JKHY), Caci International (CACI), Science Applications International (SAIC), Verint Systems (VRNT), NetScout Systems (NTCT), Scientific Games (SGMS), Allscripts Healthcare Solutions (MDRX), Ebix (EBIX), Nextgen Healthcare (NXGN), Sykes Enterprises (SYKE) and Digimarc (DMRC). What other stocks do shareholders of Cerner own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cerner investors own include Dominion Energy (d), Cisco Systems (CSCO), Gilead Sciences (GILD), QUALCOMM (QCOM), Celgene (CELG), NVIDIA (NVDA), Intel (INTC), Micron Technology (MU), Netflix (NFLX) and Walt Disney (DIS). Who are Cerner's key executives? Cerner's management team includes the folowing people: Mr. David Brent Shafer, Chairman & CEO (Age 62)Mr. Marc G. Naughton, Exec. VP & CFO (Age 64)Mr. Michael R. Nill, Exec. VP & COO (Age 54)Mr. Jeffrey A. Townsend, Exec. VP & Chief of Innovation (Age 55)Mr. John T. Peterzalek, Exec. VP & Chief Client Officer (Age 58) Who are Cerner's major shareholders? Cerner's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.35%), Wellington Management Group LLP (4.40%), Loomis Sayles & Co. L P (4.09%), Parnassus Investments CA (3.49%), Geode Capital Management LLC (1.41%) and American Century Companies Inc. (1.10%). Company insiders that own Cerner stock include Clifford W Illig, David Brent Shafer, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, John J Greisch, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, R Halsey Wise, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner. Which institutional investors are selling Cerner stock? CERN stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, OppenheimerFunds Inc., FMR LLC, Alta Capital Management LLC, Amundi Pioneer Asset Management Inc., Geode Capital Management LLC, State of Tennessee Treasury Department and TD Asset Management Inc.. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, Denis A Cortese, Julie M Wilson, Linda M Dillman, Michael R Battaglioli, Randy D Sims and Zane M Burke. View Insider Buying and Selling for Cerner. Which institutional investors are buying Cerner stock? CERN stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Parnassus Investments CA, Wellington Management Group LLP, AQR Capital Management LLC, MERIAN GLOBAL INVESTORS UK Ltd, Goldman Sachs Group Inc., Confluence Investment Management LLC and First Trust Advisors LP. Company insiders that have bought Cerner stock in the last two years include John J Greisch and R Halsey Wise. View Insider Buying and Selling for Cerner. How do I buy shares of Cerner? Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cerner's stock price today? One share of CERN stock can currently be purchased for approximately $70.14. How big of a company is Cerner? Cerner has a market capitalization of $22.83 billion and generates $5.37 billion in revenue each year. The company earns $630.05 million in net income (profit) each year or $2.21 on an earnings per share basis. Cerner employs 29,200 workers across the globe. What is Cerner's official website? The official website for Cerner is http://www.cerner.com/. How can I contact Cerner? Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected] MarketBeat Community Rating for Cerner (NASDAQ CERN)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 908 (Vote Outperform)Underperform Votes: 570 (Vote Underperform)Total Votes: 1,478MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/22/2019 by MarketBeat.com StaffFeatured Article: How Do Front-End Loads Impact an Investment? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.